跳轉至內容
Merck
全部照片(1)

Key Documents

SML2106

Sigma-Aldrich

罗氟普拉姆

≥98% (HPLC)

同義詞:

1- [4-(二氟甲氧基)-3-[(四氢-3-呋喃基)氧基]苯基] -3-甲基-1-丁酮, FFPM, ZL-n-91

登入查看組織和合約定價


About This Item

經驗公式(希爾表示法):
C16H20F2O4
CAS號碼:
分子量::
314.32
分類程式碼代碼:
51111800
NACRES:
NA.77

化驗

≥98% (HPLC)

形狀

oil

顏色

colorless to light brown

儲存溫度

2-8°C

SMILES 字串

O=C(CC(C)C)C1=CC=C(OC(F)F)C(OC2CCOC2)=C1

生化/生理作用

Roflupram(FFPM)是有效的抗炎性磷酸二酯酶4(PDE4)抑制剂,可通过增强自噬抑制小胶质细胞炎性体活化。在小胶质细胞BV-2中,roflupram提高了微管相关蛋白1轻链3 Ⅱ(LC3-II)的水平,降低了自噬受体泛素结合蛋白p62(SQSTM1),从而增强自噬、降低炎性体的活化、抑制IL-1β的产生。 发现roflupram(FFPM)可以逆转APP/PS1转基因小鼠的学习和记忆缺陷。

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析證明 (COA)

輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Tingting You et al.
ACS chemical neuroscience, 8(11), 2381-2392 (2017-06-13)
Inhibition of phosphodiesterase 4 (PDE4) suppressed the inflammatory responses in the brain. However, the underlying mechanisms are poorly understood. Roflupram (ROF) is a novel PDE4 inhibitor. In the present study, we found that ROF enhanced the level of microtubule-associated protein
Hui-Fang Tang et al.
International immunopharmacology, 10(4), 406-411 (2010-01-16)
In the present study, we investigated the effect of classic PDE4 inhibitor rolipram and novel PDE4 inhibitor ZL-n-91 on LPS-induced acute lung injury (ALI) in mice and its mechanism. ALI was induced in ICR mice by instilling intratracheally with LPS
Shilong Zheng et al.
Journal of medicinal chemistry, 51(24), 7673-7688 (2008-12-04)
Phosphodiesterase 4 catalyzes the hydrolysis of cyclic AMP and is a target for the development of anti-inflammatory agents. We have designed and synthesized a series of phenyl alkyl ketones as PDE4 inhibitors. Among them, 13 compounds were identified as having
Haibiao Guo et al.
Neuropharmacology, 116, 260-269 (2017-01-10)
Thus far, phosphodiesterase-4 (PDE4) inhibitors have not been approved for application in Alzheimer's disease (AD) in a clinical setting due to severe side effects, such as nausea and vomiting. In this study, we investigated the effect of FFPM, a novel
Dan Li et al.
International immunopharmacology, 90, 107176-107176 (2020-11-28)
Roflupram (ROF) is a novel phosphodiesterase 4 inhibitor. We previously found that ROF suppressed the production of pro-inflammatory factors in microglial cells; however, the underlying mechanisms are largely unknown. The present study aimed to elucidate the underlying molecular mechanisms of

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務